Vol 2013, No 4 (2013)

Table of Contents

Research & Development

Celgene Endorses Presage Biosciences’ Cancer Drug Analysis Platform with Strategic Collaboration Abstract
Heather Cartwright
Presidio and Boehringer Ingelheim Partner to Test All-Oral Combination for HCV Genotype-1a Abstract
Heather Cartwright
AstraZeneca Places US$240 M Bet on Moderna Therapeutics’ mRNA Technology Abstract
Heather Cartwright
Celgene Partners with Bluebird Bio to Advance CAR T-Cell Cancer Therapies Abstract
Heather Cartwright
Astellas Adds to Antibody-Drug Conjugate Capabilities with Ambrx Collaboration Abstract
Heather Cartwright
Pfizer Becomes BIND Therapeutics’ Second Major Nanomedicine Collaborator Abstract
Heather Cartwright
Isis Advances Antisense Drug for Huntington’s Disease in Collaboration with Roche Abstract
Heather Cartwright
Santaris Pharma Gains Another Collaborator in BMS Abstract
Heather Cartwright
Roche Sharpens its Focus on Chinese HCV Market with Ascletis Collaboration Abstract
Heather Cartwright
AstraZeneca Highlights R&D Growth Strategy via Collaborations with BIND Therapeutics and Horizon Discovery Abstract
Heather Cartwright

Licensing

AbbVie Licenses Phase II-Ready Antibody Programme to Receptos for Development in Eosinophilic Oesophagitis Abstract
Heather Cartwright
NPS Pharmaceuticals Regains Global Rights to Two Orphan Drugs from Takeda Abstract
Heather Cartwright
Lundbeck and Otsuka Expand Alliance with Deal for Late-Stage Alzheimer’s Disease Programme Abstract
Heather Cartwright
Dainippon Sumitomo Licenses Japanese Rights to Two Redox-Directed Drugs from Edison Pharmaceuticals Abstract
Heather Cartwright

Mergers & Acquisitions

Ajinomoto Expands Biologics Development and Manufacturing Capabilities with Althea Technologies Purchase Abstract
Heather Cartwright
Valeant Increases Offer for Obagi Medical Products After Merz Pharma Bid Abstract
Heather Cartwright
Shire Adds Phase III Ophthalmology Asset to Pipeline with SARcode Bioscience Purchase Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.